Industrial Scientists

I was truly surprised by your lead article "Scientists Wary As New Year Dawns" ["Science In 1991,"The Scientist, Jan. 7, 1991, page 1] by Julia King, in which no industrial scientists were asked for their opinions. (The Bell Labs are a minor exception, since they do not reflect the true industrial laboratory setting in our country.) Indeed, the article seemed to confirm overwhelmingly the short shrift given industrial science by The Scientist. Most scientists work in industry, and we feel tha

Written byPhilip Wyatt
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

not reflect the true industrial laboratory setting in our country.) Indeed, the article seemed to confirm overwhelmingly the short shrift given industrial science by The Scientist.

Most scientists work in industry, and we feel that our contributions play at least as great a role as those of the academic community in maintaining America's scientific and technological leadership. We win NIH and NSF grants. We make the better tools and develop many of the techniques by which means academic scientists achieve their breakthroughs. We work just as hard, are just as bright (and dull!), and just as driven as our academic colleagues.

Indeed, as a group, industrial scientists probably have a far better idea of what should be done to maintain our country's scientific leadership than do our academic colleagues.

PHILIP J. WYATT
President
Wyatt Technology Corp.
Santa Barbara, Calif.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies